andy pettitte getty

Jon Heyman once again falsely accuses Andy Pettitte of changing his testimony in the Clemens case


Jon Heyman has a silly and superfluous column up today in which he attempts to turn a couple of random recent news stories involving PED-associated ballplayers into some big trend piece about PEDs in baseball.  He references two guys — Mark McGwire and Jason Giambi — whose PED stories are years old, and then name-checks Melky Cabrera and Bartolo Colon.  But heck, even he’s only half buying it:

 It seems half the positive news so far regards folks with positive tests. Technically, that isn’t true. But it does seem that way.

Whatever. Everyone’s gotta write a column. It’s not even the worst one we’ve seen from a famous national writer today.But it does contain one passage which is as odious as it is wrong, and Heyman should know better:

Meanwhile, the Yankees are waiting on former HGH user Andy Pettitte, who is due to tell them any day whether he’d like to return for what promises to be a substantial raise from the $2.5 million he made last year after he announced his comeback in spring training.

That’s no surprise. He performed very well on the field after he came back, much better than he did in the courtroom, where he testified he couldn’t really recall whether Roger Clemens told him he had used HGH only one day after testifying Clemens did, in fact, tell him he used HGH.

Odd that he recalled a 10-year-old conversation one day, then couldn’t remember the same 10-year-old conversation the next day on the stand.

This is flat wrong.  The “Pettitte changed his testimony” line was widely parroted (including by Heyman himself) last spring when Roger Clemens was acquitted.  Some even went so far as to accuse him of perjury.  But as I demonstrated the very day it happened, Pettitte did nothing of the sort. He didn’t change his story. Not one bit. You can read the details of that here. The short version: Pettitte was consistent for years. The prosecution overreached, mischaracterized what he said and tried to contort it to its own ends, but Pettitte’s story never changed.

Heyman should have known this then.  He should definitely know it by now. The fact that he still clings to the idea that Pettitte lied under oath or changed his story is repugnant and demands a retraction.

Shelby Miller snaps 24-start winless streak

Shelby Miller
AP Photo/John Bazemore
Leave a comment

Pitcher wins are stupid, but players do seem to put some stock in them. And so Braves starter Shelby Miller can finish his 2015 season with some positive vibes.

The right-hander held the Cardinals scoreless over eight innings in the first half of a doubleheader Sunday afternoon at Turner Field, an eventual 6-0 victory for the host Braves. Miller struck out seven, gave up only three hits, and finally got some run support to snap a 24-start “winless” streak. (Atlanta was actually 3-21 in that stretch).

Miller’s last official “win” before Sunday came May 17 in Miami. He shut out the Marlins and flirted with a no-hitter in that start.

The 24-year-old will finish the 2015 season with a 6-17 record, 3.02 ERA, 1.25 WHIP, and 171/73 K/BB ratio in 205 1/3 innings. He was traded to Atlanta from St. Louis over the winter in the four-player Jason Heyward deal and will be under the Braves’ control through at least 2018.

Heyward is scheduled to become a free agent this winter.

Adam Eaton to undergo shoulder surgery Monday

Adam Eaton
AP Photo/Paul Sancya
1 Comment

Dan Hayes of reports that White Sox outfielder Adam Eaton is scheduled to undergo arthroscopic surgery Monday on his left shoulder. It’s only a cleanup procedure, and Eaton said he expects to be cleared for fishing — offseason priorities — after just 2-3 weeks of rest and rehab.

Eaton is not in the White Sox lineup for Sunday’s season finale against the Tigers, so he’ll finish 2015 with a .287/.361/.431 batting line, 14 home runs, 18 stolen bases, and 98 runs scored in 153 games.

The 26-year-old center fielder has turned into a nice all-around player and he’s under contract through 2021 at some very reasonable rates.